Vitro Biopharma, Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vitro Biopharma, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Vitro Biopharma, Inc. Depreciation for the quarter ending July 31, 2024 was $48.3K, a 21.7% increase year-over-year.
  • Vitro Biopharma, Inc. Depreciation for the twelve months ending July 31, 2024 was $175K, a 11.1% increase year-over-year.
  • Vitro Biopharma, Inc. annual Depreciation for 2023 was $153K, a 6.58% decline from 2022.
  • Vitro Biopharma, Inc. annual Depreciation for 2022 was $164K.
  • Vitro Biopharma, Inc. annual Depreciation for 2015 was $12.6K, a 12.9% decline from 2014.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $153K -$10.8K -6.58% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 $164K Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2015 $12.6K -$1.86K -12.9% Nov 1, 2014 Oct 31, 2015 10-K 2016-09-22
2014 $14.5K Nov 1, 2013 Oct 31, 2014 10-K 2016-09-22
2012 $16.9K -$525 -3.01% Nov 1, 2011 Oct 31, 2012 10-K 2013-02-12
2011 $17.5K Nov 1, 2010 Oct 31, 2011 10-K 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.